LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
Revenue
LeMaitre Vascular Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Revenue
$219.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$17.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$42.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
LeMaitre Vascular Inc
Revenue Breakdown
Breakdown by Geography
LeMaitre Vascular Inc
|
Total Revenue:
219.9m
USD
|
|
Americas:
144.6m
USD
|
|
EMEA:
60m
USD
|
|
Asia Pacific:
15.3m
USD
|
Breakdown by Segments
LeMaitre Vascular Inc
LeMaitre Vascular Inc
Glance View
LeMaitre Vascular Inc., a company engaged in the innovation and marketing of devices for vascular surgeons, traces its roots back to a family enterprise founded on the values of craftsmanship and precision. The company was established in 1983 by George LeMaitre, a preeminent vascular surgeon whose legacy continues to resonate within its core operations. Headquartered in Burlington, Massachusetts, LeMaitre Vascular specializes in developing and selling a variety of products designed to treat peripheral vascular disease. This encompasses conditions that affect blood vessels outside the heart and brain, such as aortic aneurysms and varicose veins. With devices like grafts, patches, and endovascular stent grafts, LeMaitre meets the need for effective surgical tools, facilitating procedures that enhance patient outcomes and surgical efficiency. The company generates revenue primarily through the sale and distribution of its diverse product line to hospitals and surgeons. LeMaitre Vascular leverages a direct sales model, hiring an adept sales force across the globe that builds strong relationships with clinicians. This direct approach is complemented by carefully selected distributors in regions less accessible by its direct sales teams. A key aspect of their strategy is constant innovation, where they thoughtfully assimilate advanced techniques and materials, frequently through strategic acquisitions of smaller firms with promising technologies. This dedication to development, alongside meticulous manufacturing processes, ensures that their offerings remain at the forefront of vascular surgery solutions, thereby sustaining financial growth and a robust competitive edge in a specialized market.
See Also
What is LeMaitre Vascular Inc's Revenue?
Revenue
219.9m
USD
Based on the financial report for Dec 31, 2024, LeMaitre Vascular Inc's Revenue amounts to 219.9m USD.
What is LeMaitre Vascular Inc's Revenue growth rate?
Revenue CAGR 10Y
12%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for LeMaitre Vascular Inc have been 13% over the past three years , 13% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet